ReviewFrontiers in immunology2026

Engineering strategies and binding mechanisms of therapeutic anti-PD-1 antibodies approved by regulatory agencies globally.

Juan C Almagro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.